UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2009-05, Vol.136 (5), p.1561-1567

2009

Volltextzugriff (PDF)

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

PloS one, 2013-03, Vol.8 (3), p.e60094

2013

Volltextzugriff (PDF)

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

Scandinavian journal of gastroenterology, 2017-01, Vol.52 (6-7), p.722-729

2017

Volltextzugriff (PDF)

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Therapeutic advances in gastroenterology, 2021, Vol.14, p.17562848211023386-17562848211023386

2021

Volltextzugriff (PDF)

Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males

Gastroenterology (New York, N.Y. 1943), 2010-05, Vol.138 (5), p.1697-1703.e2

2010

Volltextzugriff (PDF)

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study

Therapeutic advances in gastroenterology, 2023, Vol.16, p.17562848231174953-17562848231174953

2023

Volltextzugriff (PDF)

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG

Scandinavian journal of gastroenterology, 2021, Vol.56 (11), p.1304-1311

2021

Volltextzugriff (PDF)

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study

European journal of gastroenterology & hepatology, 2016-11, Vol.28 (11), p.1320-1328

2016

Volltextzugriff (PDF)

Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

Scandinavian journal of gastroenterology, 2018-11, Vol.53 (10-11), p.1257-1263

2018

Volltextzugriff (PDF)

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease

BMC gastroenterology, 2010-07, Vol.10 (1), p.73-73, Article 73

2010

Volltextzugriff (PDF)

Randomised, Double-blind, Placebo-controlled Trial of CCR9-targeted Leukapheresis Treatment of Ulcerative Colitis Patients

Journal of Crohn's and colitis, 2017-05, Vol.11 (5), p.534

2017

Volltextzugriff (PDF)

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study

Inflammatory bowel diseases, 2012-02, Vol.18 (2), p.212-218

2012

Volltextzugriff (PDF)

Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease

Scandinavian journal of gastroenterology, 2014-01, Vol.49 (1), p.66-74

2014

Volltextzugriff (PDF)

Naïve T cells in the gut: how to really find them?

Scandinavian journal of gastroenterology, 2014-04, Vol.49 (4), p.518-518

2014

Volltextzugriff (PDF)

Colitis‐associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer

Inflammatory bowel diseases, 2011-05, Vol.17 (5), p.1101-1107

2011

Volltextzugriff (PDF)

Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: The first 100 patients treated in Scandinavia

Scandinavian journal of gastroenterology, 2007, Vol.42 (2), p.221-227

2007

Volltextzugriff (PDF)

HLA-DRhi and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD

Clinical and translational gastroenterology, 2012-12, Vol.3 (12), p.e29

2012

Volltextzugriff (PDF)

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

Gastroenterology (New York, N.Y. 1943), 2001-05, Vol.120 (6), p.1356-1362

2001

Volltextzugriff (PDF)

Mesalazine-induced renal calculi

The American journal of case reports, 2013-01, Vol.14, p.551-553

2013

Volltextzugriff (PDF)

The sentinel node technique is useful for studies of intestinal immunology in inflammatory bowel disease patients

European journal of gastroenterology & hepatology, 2008-10, Vol.20 (10), p.985-988

2008

Volltextzugriff (PDF)

Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Gastroenterology (New York, N.Y. 1943), 2005, Vol.128 (7), p.1805-1811

2005

Volltextzugriff (PDF)

Treatment of inflammatory bowel disease by chemokine receptor-targeted leukapheresis

Clinical immunology (Orlando, Fla.), 2013-10, Vol.149 (1), p.73-82

2013

Volltextzugriff (PDF)

The Relationship between Complementary and Alternative Medicine and Disease Related Concerns in Patients with Inflammatory Bowel Disease: A Mixed Methods Approach

Quality in primary care, 2016, Vol.24 (6), p.263

2016

Volltextzugriff (PDF)

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study

Alimentary pharmacology & therapeutics, 2010-10, Vol.32 (8), p.984-989

2010

Volltextzugriff (PDF)

Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study

The Lancet (British edition), 2001-01, Vol.357 (9252), p.262-266

2001

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study

Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease

Randomised, Double-blind, Placebo-controlled Trial of CCR9-targeted Leukapheresis Treatment of Ulcerative Colitis Patients

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study

Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease

Naïve T cells in the gut: how to really find them?

Colitis‐associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer

Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: The first 100 patients treated in Scandinavia

HLA-DRhi and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

Mesalazine-induced renal calculi

The sentinel node technique is useful for studies of intestinal immunology in inflammatory bowel disease patients

Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Treatment of inflammatory bowel disease by chemokine receptor-targeted leukapheresis

The Relationship between Complementary and Alternative Medicine and Disease Related Concerns in Patients with Inflammatory Bowel Disease: A Mixed Methods Approach

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study

Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study

Suchergebnisse filtern